D-0744-2026 Class I Ongoing

Recalled by Sunny Pharmtech Inc. — Taoyuan City

FDA drug recall D-0744-2026 was initiated by Sunny Pharmtech Inc. on Jul 17, 2026 and is designated Class I. Reason for recall: Presence of Particulate Matter; identified as stainless steel The recall status is ongoing. Affected quantity: 1,464 vials.

Recall details

Product Type
Drugs
Report Date
Aug 12, 2026
Initiation Date
Jul 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,464 vials

Product description

Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1

Reason for recall

Presence of Particulate Matter; identified as stainless steel

Distribution pattern

USA Nationwide

Code information

Lot # V24010V1, Exp 3/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0744-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0744-2026. Report a data issue: hello@regdatalab.com.